EP4208462A4 - Rivaroxabanzusammensetzungen - Google Patents

Rivaroxabanzusammensetzungen Download PDF

Info

Publication number
EP4208462A4
EP4208462A4 EP21863854.2A EP21863854A EP4208462A4 EP 4208462 A4 EP4208462 A4 EP 4208462A4 EP 21863854 A EP21863854 A EP 21863854A EP 4208462 A4 EP4208462 A4 EP 4208462A4
Authority
EP
European Patent Office
Prior art keywords
rivaroxaban
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21863854.2A
Other languages
English (en)
French (fr)
Other versions
EP4208462A1 (de
Inventor
Vaibhavi SHAH
Ravindranath Gampa
Asis MAITI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inventia Healthcare Ltd India
Original Assignee
Inventia Healthcare Ltd
Inventia Healthcare Ltd India
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inventia Healthcare Ltd, Inventia Healthcare Ltd India filed Critical Inventia Healthcare Ltd
Publication of EP4208462A1 publication Critical patent/EP4208462A1/de
Publication of EP4208462A4 publication Critical patent/EP4208462A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
EP21863854.2A 2020-09-05 2021-09-04 Rivaroxabanzusammensetzungen Pending EP4208462A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202021038382 2020-09-05
PCT/IN2021/050855 WO2022049602A1 (en) 2020-09-05 2021-09-04 Rivaroxaban compositions

Publications (2)

Publication Number Publication Date
EP4208462A1 EP4208462A1 (de) 2023-07-12
EP4208462A4 true EP4208462A4 (de) 2024-09-11

Family

ID=80491661

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21863854.2A Pending EP4208462A4 (de) 2020-09-05 2021-09-04 Rivaroxabanzusammensetzungen

Country Status (2)

Country Link
EP (1) EP4208462A4 (de)
WO (1) WO2022049602A1 (de)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006072367A1 (de) * 2004-12-24 2006-07-13 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung
WO2010146179A2 (en) * 2009-06-18 2010-12-23 Krka, Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising rivaroxaban
US20170000799A1 (en) * 2013-12-23 2017-01-05 Laboratorios Del Dr. Esteve, S.A. Oral pharmaceutical composition
US20180214453A1 (en) * 2015-08-05 2018-08-02 Interquim, S.A. Rivaroxaban pharmaceutical compositions
CN109419778A (zh) * 2017-08-22 2019-03-05 正大天晴药业集团股份有限公司 一种利伐沙班片剂及其制备方法
EP3505160A1 (de) * 2017-12-31 2019-07-03 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Herstellung einer festen pharmazeutischen zusammensetzung mit rivaroxaban und herstellung davon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
WO2013022924A1 (en) * 2011-08-08 2013-02-14 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations
WO2015124995A1 (en) * 2014-02-19 2015-08-27 Aurobindo Pharma Ltd Solid dosage forms of rivaroxaban

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006072367A1 (de) * 2004-12-24 2006-07-13 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung
WO2010146179A2 (en) * 2009-06-18 2010-12-23 Krka, Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising rivaroxaban
US20170000799A1 (en) * 2013-12-23 2017-01-05 Laboratorios Del Dr. Esteve, S.A. Oral pharmaceutical composition
US20180214453A1 (en) * 2015-08-05 2018-08-02 Interquim, S.A. Rivaroxaban pharmaceutical compositions
CN109419778A (zh) * 2017-08-22 2019-03-05 正大天晴药业集团股份有限公司 一种利伐沙班片剂及其制备方法
EP3505160A1 (de) * 2017-12-31 2019-07-03 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Herstellung einer festen pharmazeutischen zusammensetzung mit rivaroxaban und herstellung davon

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2022049602A1 *

Also Published As

Publication number Publication date
EP4208462A1 (de) 2023-07-12
WO2022049602A1 (en) 2022-03-10

Similar Documents

Publication Publication Date Title
EP4227390A4 (de) Kühlmittel enthaltende zusammensetzung
EP4148096A4 (de) Zusammensetzung
EP4094582A4 (de) Zusammensetzung
EP4328279A4 (de) Zusammensetzung
EP4115893A4 (de) Antitumorzusammensetzung
EP4279545A4 (de) Zusammensetzung
EP4244818A4 (de) Disambiguierung von posen
EP4313320A4 (de) Schweisshemmende zusammensetzung
EP4181916A4 (de) Feste delta9-tetrahydrocannabinol (delta9-thc) zusammensetzungen
EP4281046C0 (de) Naltrexonzusammensetzungen
EP4372077A4 (de) Autophagieaktivierende zusammensetzung
EP4337752C0 (de) Zusammensetzung
EP4330366C0 (de) Zusammensetzung
EP4256012C0 (de) Zusammensetzung
EP4291042C0 (de) Haferabgeleitete zusammensetzung
CR20240192A (es) Composiciones farmacéuticas de efruxifermina
EP4208462A4 (de) Rivaroxabanzusammensetzungen
EP4452252A4 (de) Oxazolidinonliposomzusammensetzungen
EP4504168A4 (de) Cannabinoidhaltige zusammensetzungen
EP4454715A4 (de) Zusammensetzung
EP4509561A4 (de) Zusammensetzung
EP4473837A4 (de) Zusammensetzung
EP4469037A4 (de) Antimikrobielle zusammensetzungen
EP4403170A4 (de) Caryophyllenhaltige zusammensetzung
EP4393305A4 (de) Zusammensetzung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230317

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INVENTIA HEALTHCARE LIMITED

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240809

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 413/14 20060101ALI20240805BHEP

Ipc: A61K 9/28 20060101ALI20240805BHEP

Ipc: A61P 7/00 20060101ALI20240805BHEP

Ipc: A61P 3/00 20060101ALI20240805BHEP

Ipc: A61K 9/20 20060101ALI20240805BHEP

Ipc: A61K 31/5377 20060101ALI20240805BHEP

Ipc: C07D 413/10 20060101AFI20240805BHEP

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INVENTIA HEALTHCARE LIMITED

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INVENTIA HEALTHCARE LIMITED

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20260116